1684393-04-1

1684393-04-1 structure
1684393-04-1 structure
  • Name: Rosmantuzumab
  • Chemical Name: Rosmantuzumab
  • CAS Number: 1684393-04-1
  • Molecular Formula:
  • Molecular Weight:
  • Catalog: Research Areas Cancer
  • Create Date: 2023-04-04 17:41:10
  • Modify Date: 2024-04-05 18:06:23
  • Rosmantuzumab (OMP-131R10) is an anti-R-spondin 3 (RSPO3) humanized monoclonal antibody. Rosmantuzumab can be used for the research of advanced telapsed and refractory solid tumors[1].

Name Rosmantuzumab
Description Rosmantuzumab (OMP-131R10) is an anti-R-spondin 3 (RSPO3) humanized monoclonal antibody. Rosmantuzumab can be used for the research of advanced telapsed and refractory solid tumors[1].
Related Catalog
In Vivo Rosmantuzumab (25 mg/kg;腹腔注射,每周一次,持续 4 周) 显著保护动物免于发生肝纤维化[1]。 Rosmantuzumab (25mg /kg;腹腔注射,每两周一次,持续 6 周) 在博莱霉素诱导的肺纤维化小鼠模型中,显著抑制皮肤厚度、胶原沉积和 α-SMA 阳性细胞数量[1]。 Animal Model: Male C57B1/6J CCl4 liver fibrosis mouse models[1] Dosage: 25 mg/kg Administration: Intraperitoneal injection; 25 mg/kg, once a week for 4 weeks Result: Significantly decreased collagen I and collagen III mRNAs, and inhibits β-catenin cytoplasmic and nuclear translocation.
References

[1]. Zhang M, et al. Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs. PLoS One. 2020 Mar 11;15(3):e0229445.  

No Any Chemical & Physical Properties
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.